NCT04696406View on ClinicalTrials.gov

Multicenter, Multinational, Clinical Trial of the Performance of RESPINOR DXT to Identify Patients at Increased Risk of Weaning Failure

CompletedOBSERVATIONAL
Enrollment

193

Participants

Timeline

Start Date

May 11, 2021

Primary Completion Date

March 30, 2022

Study Completion Date

April 30, 2022

Conditions
Respiratory Failure
Interventions
DEVICE

RESPINOR DXT

Blinded, continuous diaphragmatic excursion measurements by DXT will be conducted during the patients' first SBT. The recording shall be initiated 15 minutes prior to the first SBT and will end 15 minutes post SBT.

Trial Locations (9)

13015

Hôpitaux Universitaires de Marseille - AP-HM, Marseille

34090

Centre Hospitalier Universitaire de Montpellier, Montpellier

75571

Hopital Saint-Antoine, Paris

Unknown

Centre Hospitalier Universitaire d'Angers, Angers

Centre Hospitalier Saint Joseph Saint Luc, Lyon

Hôpital Universitaire Pitié Salpêtrière, Paris

Ospedale San Carlo Borromeo, Milan

Oslo University Hospital, Oslo

St. Olavs University Hospital, Trondheim

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

lead

Respinor AS

INDUSTRY